DEA Extends Forms on Your Drug Use Disclosures
Published Date: 1/28/2026
Notice
Summary
The Drug Enforcement Administration wants to keep collecting info about drug use statements and is asking for your feedback for 30 days until February 27, 2026. This affects people who provide this info and aims to make the process easier and clearer, possibly using electronic forms. No big cost changes are expected, just a smooth extension of the current system.
Analyzed Economic Effects
1 provisions identified: 0 benefits, 1 costs, 0 mixed.
DEA Job Applicants Must Complete Drug Form
If you apply for a job at the Drug Enforcement Administration (DEA), you will be asked to fill out Form DEA-200, the Pre‑Employment Drug Policy Notification and Acknowledgement. The agency estimates 4,727 applicants will respond and the form takes about 7 minutes to complete each (total annual time burden 551 hours); failing to provide the acknowledgement can lead to disqualification in the hiring process. DOJ seeks OMB authorization for three years, allows electronic submission to reduce burden, and is accepting public comments for 30 days until February 27, 2026.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Related Federal Register Documents
2026-11526 — Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment
Starting July 9, 2026, new rules make it easier for doctors and pharmacies to provide medicine that helps people recover from opioid addiction. These changes affect healthcare providers by expanding who can give medication-assisted treatment and how pharmacies can deliver these medicines. The goal? Faster, safer access to treatment with clear rules that save time and support recovery.
2026-10128 — Revision of Applications for Manufacturing and Procurement Quotas
The DEA wants to update how companies apply for permission to make and buy certain controlled drugs and chemicals. These changes will make the rules clearer, help prevent drug shortages, and ensure enough supply for medical and scientific needs. If you’re a manufacturer or involved in this process, get ready to follow new steps and share your thoughts by July 20, 2026.
2026-09160 — Implementing PATRIOT Act Improvements: Contraband Cigarettes and Smokeless Tobacco
Starting June 8, 2026, new rules crack down harder on illegal cigarette and smokeless tobacco sales. The government lowered the amount that counts as smuggling from 60,000 to just 10,000 cigarettes and now includes smokeless tobacco in the crackdown. Sellers and distributors must keep better records and report more info, making it tougher to dodge the law and protect honest businesses.
2026-13821 — Schedules of Controlled Substances: Placement of Tianeptine in Schedule I
The DEA wants to put tianeptine, a drug with potential risks, into Schedule I, meaning it’ll be treated like the most tightly controlled substances. This change affects anyone who makes, sells, studies, or uses tianeptine, bringing strict rules and penalties. You’ve got until August 7, 2026, to share your thoughts before the new rules could kick in.
2026-13705 — Importer of Controlled Substances Application: Benuvia Operations, LLC.
Benuvia Operations, LLC wants to become an official importer of certain controlled substances like marijuana extract and psilocybin. People and companies involved with these drugs can share their thoughts or ask for a hearing by August 6, 2026. This move could shake up who gets to bring these substances into the U.S., so keep an eye on the deadline if you’re interested!
2026-13721 — Notice of Lodging of Proposed Consent Decree Under the Comprehensive Environmental Response, Compensation and Liability Act (CERCLA)
The Columbia Falls Aluminum Company (CFAC) will pay back $1.8 million for past pollution cleanup and cover future costs, which could total over $57 million, to clean up a hazardous site in Montana. In return, the government promises not to sue CFAC again for this pollution. The public has 30 days to share their thoughts on this cleanup deal.
Previous / Next Documents
Previous: 2026-01702 — Foreign-Trade Zone 68; Application for Subzone; PMI Services North America, Inc.; El Paso, Texas
The City of El Paso wants to add a special trade zone called a subzone for PMI Services North America, Inc. at their El Paso facility. This change helps the company handle imports and exports more easily, but no production activities are planned yet. People have until March 9, 2026, to share their thoughts before a final decision is made.
Next: 2026-01704 — Atomic Alchemy Operators LLC; VIPR Idaho LLC; Construction Permit Application
Atomic Alchemy Operators LLC and VIPR Idaho LLC have decided to pull back their plan to build a special isotope production reactor at Idaho National Laboratory. This means no new construction will happen there for now, saving time and money on the project. The Nuclear Regulatory Commission officially accepted this withdrawal on January 28, 2026.